| Catalog No. |
Size |
Price |
Figures |
|---|
Z00058-1 mg
| 1 mg | $ 420.00 |
References:
- Connolly SA, et al. Potential nectin-1 binding site on herpes simplex virus glycoprotein d. J. Virol. Jan 2005; 79(2): 1282-1295.
- Osorio Y, et al. Improved protection from primary ocular HSV-1 infection and establishment of latency using multigenic DNA vaccines. Invest. Ophthalmol. Vis. Sci. Feb 2004; 45(2): 506-514.
- Hruby DE. Vaccinia virus vectors: new strategies for producing recombinant vaccines. Clin. Microbiol. Rev. Apr 1990; 3(2): 153-170.
|
|---|
| Full Name | | Herpes Simplex Virus (HSV)-1 gD |
|
| Abbreviated Name-1 | Herpes Simplex Virus-1gD |
|---|
| Abbreviated Name-2 | HSV-1 gD |
|---|
| Description | Herpes Simplex Virus (HSV)-1 gD is a E. coli-derived recombinant. The protein contains the HSV-1 gD immunodominant regions. HSV-1-gD is purified by proprietary chromatographic techniques.
|
|---|
| Source | E. coli |
|---|
| Purity | The protein is >95% pure as determined by 10% PAGE (Coomassie staining). |
|---|
| Storage | The protein is shipped at ambient temperature. Upon arrival, store it at -20°C. |
|---|
| Concentration | 1 mg/ml in 25 mM Tris-HCl, 1 mM EDTA, 50% glycerol |
|---|
| Stability | The protein will remain stable for five years if stored frozen and for one month in solution if stored at room temperature. |
|---|
| Specificity | The protein is immunoreactive with sera of HSV-infected individuals. |
|---|
| Applications | The protein can serve as an antigen in ELISA and Western Blots and an excellent antigen in the detection of HSV. It shows minimal specificity problems.
|
|---|
